Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity.

Hendricks EJ, Greenway FL, Westman EC, Gupta AK.

Obesity (Silver Spring). 2011 Dec;19(12):2351-60. doi: 10.1038/oby.2011.94. Epub 2011 Apr 28.

2.

Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.

Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.

J Hum Hypertens. 2002 Jan;16(1):13-9.

3.

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.

McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K; Sibutramine in Hypertensives Clinical Study Group.

J Hum Hypertens. 2002 Jan;16(1):5-11.

4.

Long-term changes in blood pressure following orlistat and sibutramine treatment: a meta-analysis.

Johansson K, Sundström J, Neovius K, Rössner S, Neovius M.

Obes Rev. 2010 Nov;11(11):777-91. doi: 10.1111/j.1467-789X.2009.00693.x. Review.

PMID:
20025693
5.

Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.

Aronne LJ, Halseth AE, Burns CM, Miller S, Shen LZ.

Obesity (Silver Spring). 2010 Sep;18(9):1739-46. doi: 10.1038/oby.2009.478. Epub 2010 Jan 21.

6.

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study.

Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, Schwiers M, Day WW, Bowden CH.

Am J Clin Nutr. 2012 Feb;95(2):297-308. doi: 10.3945/ajcn.111.024927. Epub 2011 Dec 7.

7.

Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.

Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.

Diabetes Nutr Metab. 2004 Aug;17(4):222-9.

PMID:
15575343
8.

A comparative study of phentermine and diethylpropion in the treatment of obese patients in general practice.

Vallé-Jones JC, Brodie NH, O'Hara H, O'Hara J, McGhie RL.

Pharmatherapeutica. 1983;3(5):300-4.

PMID:
6844367
9.
10.
11.

Orlistat in hypertensive overweight/obese patients: results of a randomized clinical trial.

Bloch KV, Salles GF, Muxfeldt ES, Da Rocha Nogueira A.

J Hypertens. 2003 Nov;21(11):2159-65.

PMID:
14597860
12.

Effect of orlistat-assisted weight loss on endothelium-dependent vasodilation in obese Chinese subjects with hypertension.

Liu J, Sun N, Yang S, Ma Z, Yang J.

Clin Exp Hypertens. 2010;32(6):395-9. doi: 10.3109/10641961003667906. Epub 2010 Aug 31.

PMID:
20804448
13.

Effects of GH replacement on 24-h ambulatory blood pressure and its circadian rhythm in adult GH deficiency.

Ahmad AM, Hopkins MT, Weston PJ, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2002 Apr;56(4):431-7.

PMID:
11966735
14.

Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.

Derosa G, Cicero AF, Murdolo G, Piccinni MN, Fogari E, Bertone G, Ciccarelli L, Fogari R.

Diabetes Obes Metab. 2005 Jan;7(1):47-55.

PMID:
15642075
15.

Effect of a weight-loss program on mental stress-induced cardiovascular responses and recovery.

Torres SJ, Nowson CA.

Nutrition. 2007 Jul-Aug;23(7-8):521-8. Epub 2007 Jun 7.

PMID:
17560080
16.

A review of the metabolic effects of controlled-release Phentermine/Topiramate.

Kiortsis DN.

Hormones (Athens). 2013 Oct-Dec;12(4):507-16. Review.

17.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
18.

Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP).

Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, Tam PY, Troupin B, Day WW.

Obesity (Silver Spring). 2012 Feb;20(2):330-42. doi: 10.1038/oby.2011.330. Epub 2011 Nov 3.

20.

Circadian variation and blood pressure: response to rapid weight loss by hypocaloric hyponatraemic diet in obesity.

DasGupta P, Brigden G, Ramhamdany E, Lahiri A, Baird IM, Raftery EB.

J Hypertens. 1991 May;9(5):441-7.

PMID:
1649864
Items per page

Supplemental Content

Write to the Help Desk